GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (OTCPK:GALDY) » Definitions » Net Margin %

GALDY (Galderma Group AG) Net Margin % : 8.27% (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Galderma Group AG's Net Income for the six months ended in Dec. 2024 was $184 Mil. Galderma Group AG's Revenue for the six months ended in Dec. 2024 was $2,224 Mil. Therefore, Galderma Group AG's net margin for the quarter that ended in Dec. 2024 was 8.27%.

The historical rank and industry rank for Galderma Group AG's Net Margin % or its related term are showing as below:

GALDY' s Net Margin % Range Over the Past 10 Years
Min: -1.38   Med: 1.91   Max: 5.2
Current: 5.2

GALDY's Net Margin % is ranked better than
51.89% of 979 companies
in the Drug Manufacturers industry
Industry Median: 4.59 vs GALDY: 5.20

Galderma Group AG Net Margin % Historical Data

The historical data trend for Galderma Group AG's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Net Margin % Chart

Galderma Group AG Annual Data
Trend Dec23 Dec24
Net Margin %
-1.38 5.20

Galderma Group AG Semi-Annual Data
Jun23 Dec23 Jun24 Dec24
Net Margin % 0.20 -2.90 2.12 8.27

Competitive Comparison of Galderma Group AG's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Galderma Group AG's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Galderma Group AG's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Galderma Group AG's Net Margin % distribution charts can be found below:

* The bar in red indicates where Galderma Group AG's Net Margin % falls into.


;
;

Galderma Group AG Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Galderma Group AG's Net Margin for the fiscal year that ended in Dec. 2024 is calculated as

Net Margin=Net Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=231/4440
=5.20 %

Galderma Group AG's Net Margin for the quarter that ended in Dec. 2024 is calculated as

Net Margin=Net Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=184/2224
=8.27 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galderma Group AG  (OTCPK:GALDY) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Galderma Group AG Net Margin % Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Galderma Group AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (OTCPK:GALDY) » Definitions » Net Margin %
Comparable Companies
XSWX:SDZ XSWX:SFZN XSWX:PPGN XSWX:CURN ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN HKSE:03692 NSE:DIVISLAB XTAE:TEVA ITCI SZSE:000538 UTHR BOM:500087 TSE:4507 SHSE:688506 NSE:TORNTPHARM BOM:543904
Traded in Other Exchanges
GDERF:USA GALDz:UK PY30:Germany GALD:Switzerland
Address
Zahlerweg 10, Zug, CHE, 6300
Website
https://www.galderma.com
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.